As Middle Eastern markets experience a rebound driven by strong corporate earnings and optimism from international trade agreements, investors are increasingly turning their attention to the region's ...

Generally, the birth of football’s data revolution is dated back to the mid-2000s, although companies such as Opta and ...

This is a well-written study that presents a solid genetic screen to identify regulators of adipose morphology and remodeling in zebrafish. The authors generated a rigorous screening platform based on ...

Opening the floodgates of 401K money to crypto will strengthen the financial support the crypto industry has been providing ...

Over the last 7 days, the United States market has remained flat, yet it is up 12% over the past year with earnings ...

Q3 2025 Management View CEO Stephen Mullowney provided an overview stating, "In fiscal 2024, we did over $40 million of revenue and $15 million of EBITDA. We expect those numbers to be higher this ...

PPL Corporation's transformation into a stable U.S.-regulated utility makes it a strong buy. Click here to read an analysis ...

Jeffrey R. Leitzell, EVP & COO of EOG Resources, Inc.( EOG -0.42%), executed a sale of 10,640 shares valued at ~$1.27 million ...

The authors proposed two hypotheses: first, that methamphetamine induces neuroinflammation, and second, that it alters neuronal stem cell differentiation. These are valuable hypotheses, and the ...

FLOW Historical Stock Price and Closing Data Access detailed historical stock prices, including daily closing prices, for FLOW.

Gilead’s Livdelzi® (Seladelpar) Demonstrated Consistent Efficacy and Safety Regardless of Prior Treatment History in New Data Presented at EASL 2025 – 60% of Participants with Prior Fibrate ...